Medicines and Healthcare products Regulatory Agency

MANUFACTURER'S AUTHORISATION
1: Authorisation Number UK MIA 45803
2: Name of authorisation holder ROSLIN CELL THERAPIES LIMITED
3: Address(es) of manufacturing site(s)

ROSLINCT - SHAWFAIR, 2 WESTER SHAWFAIR, DANDERHALL, DALKEITH, EH22 1FD, UNITED KINGDOM

ROSLINCT- BIOCUBE 2 , BIOCUBE 2, 11 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM

4: Legally registered address of authorisation holder ROSLIN CELL THERAPIES LIMITED, 9 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM
5: Scope of authorisation and dosage forms ANNEX 1 and/ or ANNEX 2
6: Legal Basis of authorisation
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation Confidential
8: Authorisation Date 25/02/2025
9: Annexes attached Annex 1 and/or Annex 2
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:

ROSLINCT - SHAWFAIR, 2 WESTER SHAWFAIR, DANDERHALL, DALKEITH, EH22 1FD, UNITED KINGDOM

Human Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Products
    [ 1.1.3 ] Batch certification
[ 1.3 ] Biological medicinal products
    [ 1.3.2 ] Batch certification
        [ 1.3.2.3 ] Cell therapy products
            Special Requirements
            Live Cells
        [ 1.3.2.4 ] Gene therapy products
            Special Requirements
            Live Cells
        [ 1.3.2.6 ] Human or animal extracted products
            Special Requirements
            Live Cells
SCOPE OF AUTHORISATION
Annex 1
Name and address of the site:

ROSLINCT- BIOCUBE 2 , BIOCUBE 2, 11 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM

Human Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Products
    [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms)
        [ 1.1.1.6 ] Other aseptically prepared products
            Cellular therapy products ( ATMPs), Master cell banks
            Special Requirements
            Live Cells
    [ 1.1.3 ] Batch certification
[ 1.3 ] Biological medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.3 ] Cell therapy products
            Special Requirements
            Live Cells
        [ 1.3.1.4 ] Gene therapy products
            Special Requirements
            Live Cells
        [ 1.3.1.6 ] Human or animal extracted products
            Special Requirements
            Live Cells
        [ 1.3.1.7 ] Tissue Engineered Products
            Special Requirements
            Live Cells
    [ 1.3.2 ] Batch certification
        [ 1.3.2.3 ] Cell therapy products
            Special Requirements
            Live Cells
        [ 1.3.2.4 ] Gene therapy products
            Special Requirements
            Live Cells
        [ 1.3.2.6 ] Human or animal extracted products
            Special Requirements
            Live Cells
        [ 1.3.2.7 ] Tissue Engineered Products
            Special Requirements
            Live Cells
[ 1.5 ] Packaging
    [ 1.5.1 ] Primary packaging
        [ 1.5.1.6 ] Liquids for internal use
    [ 1.5.2 ] Secondary packaging